Abstract:Objectives Increasing gradient performance on modern magnetic resonance imaging scanners has profoundly reduced the attainable diffusion and echo times for clinically available pulsed-gradient spin echo (PGSE) sequences. This study investigated how this may impact the measured apparent diffusion coefficient (ADC), which is considered an important diagnostic marker for differentiation between normal and abnormal brain tissue and for therapeutic follow-up. Materials and Methods Diffusion time and echo time dependence of the ADC were evaluated on a high-performance 3 T magnetic resonance imaging scanner. Diffusion PGSE brain scans were performed in 10 healthy volunteers and in 10 brain tumor patients using diffusion times of 16, 40, and 70 ms, echo times of 60, 75, and 104 ms at 3 b-values (0, 100, and 1000 s/mm 2 ), and a maximum gradient amplitude of 68 mT/m. A low gradient performance system was also emulated by reducing the diffusion encoding gradient amplitude to 19 mT/m. In healthy subjects, the ADC was measured in 6 deep gray matter regions and in 6 white matter regions. In patients, the ADC was measured in the solid part of the tumor. Results With increasing diffusion time, a small but significant ADC increase of up to 2.5% was observed for 6 aggregate deep gray matter structures. With increasing echo time or reduced gradient performance, a small but significant ADC decrease of up to 2.6% was observed for 6 aggregate white matter structures. In tumors, diffusion time–related ADC changes were inconsistent without clear trend. For tumors with diffusivity above 1.0 μm 2 /ms, with prolonged echo time, there was a pronounced ADC increase of up to 12%. Meanwhile, for tumors with diffusivity at or below 1.0 μm 2 /ms, no change or a reduction was observed. Similar results were observed for gradient performance reduction, with an increase of up to 21%. The coefficient of variation determined in repeat experiments was 2.4%. Conclusions For PGSE and the explored parameter range, normal tissue ADC changes seem negligible. Meanwhile, observed tumor ADC changes can be relevant if ADC is used as a quantitative biomarker and not merely assessed by visual inspection. This highlights the importance of reporting all pertinent timing parameters in ADC studies and of considering these effects when building scan protocols for use in multicenter investigations.

Apparent Diffusion Coefficient in Grading Pineal Parenchymal Tumors:a Preliminary Study

Pineal Parenchymal Tumours: Minimum Apparent Diffusion Coefficient in Prediction of Tumour Grading

The Value of Apparent Diffusion Coefficient in Differentiation of Pediatric Posterior Fossa Tumors

Apparent Diffusion Coefficient to Evaluate Adult Intracranial Ependymomas: Relationship to Ki‐67 Proliferation Index

Differentiating Primary Central Nervous System Lymphomas From Glioblastomas and Inflammatory Demyelinating Pseudotumor Using Relative Minimum Apparent Diffusion Coefficients.

Oligodendroglial Tumors: Can Relative Apparent Diffusion Coefficient Be Used in Prediction of Tumor Grade and Subtype

Correlating Apparent Diffusion Coefficients with Histopathologic Findings on Meningiomas

Comparison of ADC values of intracranial hemangiopericytomas and angiomatous and anaplastic meningiomas.

Differentiation of Low-grade Glioma and Reactive Gliosis:Diagnostic Value of Minimum Relative Apparent Diffusion Coefficient

[Correlation Between Minimal Apparent Diffusion Coefficient and Expression of Ki-67 in Glioma].

The Utility of Diffusion MRI with Quantitative ADC Measurements for Differentiating High-Grade from Low-Grade Cerebral Gliomas: Evidence from a Meta-Analysis

Apparent Diffusion Coefficient Measurement in Glioma: Influence of Region-Of-Interest Determination Methods on Apparent Diffusion Coefficient Values, Interobserver Variability, Time Efficiency, and Diagnostic Ability

Evaluating Tumors and Tumorlike Lesions of the Nasal Cavity, the Paranasal Sinuses, and the Adjacent Skull Base With Diffusion-Weighted MRI

Preliminary study on pathomechanism of non-small-cell lung carcinoma using apparent diffusion coefifcient

High-Resolution Diffusion-Weighted Imaging of C6 Glioma on a 7T BioSpec MRI Scanner: Correlation of Tumor Cellularity and Nuclear-to-Cytoplasmic Ratio with Apparent Diffusion Coefficient.

Value of Apparent Diffusion Coefficient in the Differential Diagnosis of Small Round Cell Malignant Tumors of Nasal and Paranasal Sinus

The value of DWI combined with minimum ADC value in differential diagnosis of intracranial solitary fibrous tumor/hemangiopericytoma and meningioma

Lower apparent diffusion coefficients indicate distinct prognosis in low-grade and high-grade glioma

A Preliminary Study of Pediatric Brain Tumors Using Multi-Component Diffusion Weighted Imaging

Normal Brain and Brain Tumor ADC

Differentiating between non-functioning pituitary macroadenomas and sellar meningiomas using ADC